Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors
Key Points HDACi-mediated differentiation therapy is a potent and molecularly rational treatment strategy in t(8;21) AML.
Key Points HDACi-mediated differentiation therapy is a potent and molecularly rational treatment strategy in t(8;21) AML.
h-index: Number of publications with at least h citations each.